Indication

Autonomous Cortisol Secretion

2 clinical trials

3 products

Clinical trial
SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor
Status: Recruiting, Estimated PCD: 2024-12-01
Product
SPI-62
Product
Placebo
Clinical trial
Metyrapone Intervention in Patients With Mild Autonomous Cortisol Secretion (MACS)
Status: Recruiting, Estimated PCD: 2028-01-01
Product
Metyrapone